Erdheim-Chester Disease Global Alliance

Gaurav Goyal, MD
Ron Go, MD
Oshrat Rokah, PhD
Paul Hendrie, MD, PhD
Lorenzo Dagna, MD
Unit of Clinical Immunopathology and Adv. Medical Therapeutics
San Raffaele Scientific Institute
Via Olgettina 60
20132 Milan, Italy

Lorenzo Dagna, MD
Unit of Clinical Immunopathology and Adv. Medical Therapeutics
San Raffaele Scientific Institute
Via Olgettina 60
20132 Milan, Italy
Eli L. Diamond, MD
Department of Neurology
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, Box 52
New York, NY 10065 USA

Eli L. Diamond, MD
Department of Neurology
Memorial Sloan-Kettering Cancer Center
1275 York Avenue, Box 52
New York, NY 10065 USA
Juvianee Estrada-Veras, MD
Medical Biochemical Genetics
National Institutes of Health/National Human Genome Research Institute
10 Center Drive, Bldg 10, CRC- Room 3-2551
Bethesda, MD 20892-1851 USA

Dr. Estrada-Veras also serves on the ECDGA Board of Directors. He leadership on the Natural History Study for Erdheim-Chester Disease has led to an important and in-depth understanding of ECD.
Julien Haroche, MD, PhD
Service de Médecine Interne (PrAmoura)Groupe
Hospitalier Pitié-Salpêtrière
47-83 Bd de l’Hôpital
75651 PARIS Cedex 13

Julien Haroche, MD, PhD
Service de Médecine Interne (PrAmoura)Groupe
Hospitalier Pitié-Salpêtrière
47-83 Bd de l’Hôpital
75651 PARIS Cedex 13
Razelle Kurzrock, MD, FACP
Chief Medical Officer, Chair, Clinical Trials Committee
Worldwide Innovative Network (WIN) for Personalized Cancer Therapy
California, USA

Chief Medical Officer, Chair, Clinical Trials Committee
Worldwide Innovative Network (WIN) for Personalized Cancer Therapy
California, USA
Augusto Vaglio, MD
AOU Meyer
Via G. Pieraccini 24
Firenze, ITALY

Augusto Vaglio, MD
AOU Meyer
Location: Via G. Pieraccini 24
Firenze, ITALY